These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 28689412)
1. Bexarotene Does Not Clear Amyloid Beta Plaques but Delays Fibril Growth: Molecular Mechanisms. Huy PDQ; Thai NQ; Bednarikova Z; Phuc LH; Linh HQ; Gazova Z; Li MS ACS Chem Neurosci; 2017 Sep; 8(9):1960-1969. PubMed ID: 28689412 [TBL] [Abstract][Full Text] [Related]
2. Bexarotene cannot reduce amyloid beta plaques through inhibition of production of amyloid beta peptides: in silico and in vitro study. Pham HDQ; Thai NQ; Bednarikova Z; Linh HQ; Gazova Z; Li MS Phys Chem Chem Phys; 2018 Sep; 20(37):24329-24338. PubMed ID: 30211407 [TBL] [Abstract][Full Text] [Related]
3. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study. Mirza Z; Beg MA Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487 [TBL] [Abstract][Full Text] [Related]
4. Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides. Fantini J; Di Scala C; Yahi N; Troadec JD; Sadelli K; Chahinian H; Garmy N ACS Chem Neurosci; 2014 Mar; 5(3):216-24. PubMed ID: 24383913 [TBL] [Abstract][Full Text] [Related]
5. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier. Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114 [TBL] [Abstract][Full Text] [Related]
7. Fast green FCF inhibits Aβ fibrillogenesis, disintegrates mature fibrils, reduces the cytotoxicity, and attenuates Aβ-induced cognitive impairment in mice. Liu F; Wang W; Xuan Z; Jiang L; Chen B; Dong Q; Zhao F; Cui W; Li L; Lu F Int J Biol Macromol; 2021 Feb; 170():33-41. PubMed ID: 33352157 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry. Sciacca MFM; Romanucci V; Zarrelli A; Monaco I; Lolicato F; Spinella N; Galati C; Grasso G; D'Urso L; Romeo M; Diomede L; Salmona M; Bongiorno C; Di Fabio G; La Rosa C; Milardi D ACS Chem Neurosci; 2017 Aug; 8(8):1767-1778. PubMed ID: 28562008 [TBL] [Abstract][Full Text] [Related]
9. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Cramer PE; Cirrito JR; Wesson DW; Lee CY; Karlo JC; Zinn AE; Casali BT; Restivo JL; Goebel WD; James MJ; Brunden KR; Wilson DA; Landreth GE Science; 2012 Mar; 335(6075):1503-6. PubMed ID: 22323736 [TBL] [Abstract][Full Text] [Related]
11. De novo design of self-assembled hexapeptides as β-amyloid (Aβ) peptide inhibitors. Wang Q; Liang G; Zhang M; Zhao J; Patel K; Yu X; Zhao C; Ding B; Zhang G; Zhou F; Zheng J ACS Chem Neurosci; 2014 Oct; 5(10):972-81. PubMed ID: 25133634 [TBL] [Abstract][Full Text] [Related]
12. Identification of dibenzyl imidazolidine and triazole acetamide derivatives through virtual screening targeting amyloid beta aggregation and neurotoxicity in PC12 cells. Das S; Smid SD Eur J Med Chem; 2017 Apr; 130():354-364. PubMed ID: 28273562 [TBL] [Abstract][Full Text] [Related]
13. Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM. Norlin N; Hellberg M; Filippov A; Sousa AA; Gröbner G; Leapman RD; Almqvist N; Antzutkin ON J Struct Biol; 2012 Oct; 180(1):174-89. PubMed ID: 22750418 [TBL] [Abstract][Full Text] [Related]
14. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease. Habchi J; Arosio P; Perni M; Costa AR; Yagi-Utsumi M; Joshi P; Chia S; Cohen SI; Müller MB; Linse S; Nollen EA; Dobson CM; Knowles TP; Vendruscolo M Sci Adv; 2016 Feb; 2(2):e1501244. PubMed ID: 26933687 [TBL] [Abstract][Full Text] [Related]
15. Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. LaClair KD; Manaye KF; Lee DL; Allard JS; Savonenko AV; Troncoso JC; Wong PC Mol Neurodegener; 2013 Jun; 8():18. PubMed ID: 23764200 [TBL] [Abstract][Full Text] [Related]
17. Protofibril-Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation. Hasecke F; Niyangoda C; Borjas G; Pan J; Matthews G; Muschol M; Hoyer W Angew Chem Int Ed Engl; 2021 Feb; 60(6):3016-3021. PubMed ID: 33095508 [TBL] [Abstract][Full Text] [Related]
18. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds. Dong M; Zhao W; Hu D; Ai H; Kang B ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293 [TBL] [Abstract][Full Text] [Related]
19. Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes. Kamp F; Scheidt HA; Winkler E; Basset G; Heinel H; Hutchison JM; LaPointe LM; Sanders CR; Steiner H; Huster D ACS Chem Neurosci; 2018 Jul; 9(7):1702-1713. PubMed ID: 29717863 [TBL] [Abstract][Full Text] [Related]
20. The Japanese mutant Aβ (ΔE22-Aβ(1-39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of wild-type Aβ(1-40) into atypical fibrils by ΔE22-Aβ(1-39). Cloe AL; Orgel JP; Sachleben JR; Tycko R; Meredith SC Biochemistry; 2011 Mar; 50(12):2026-39. PubMed ID: 21291268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]